Perfect Medical Industry Co., Ltd. (TPEX:6543)
Taiwan · Delayed Price · Currency is TWD 17.95
0.00 (0.00%)
Aug 19, 2026, 9:04 AM CST
Perfect Medical Industry Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 886.3 | 779.02 | 744.16 | 734.13 | 677.04 | 724.61 | |
Revenue Growth | 20.21% | 4.68% | 1.36% | 8.43% | -6.57% | -10.29% |
Cost of Revenue | 690.64 | 578.25 | 505.96 | 533.58 | 542.63 | 515.08 |
Gross Profit | 195.66 | 200.76 | 238.19 | 200.56 | 134.41 | 209.53 |
Selling, General & Admin | 146.46 | 133.61 | 135.78 | 134.78 | 123.61 | 145.44 |
Research & Development | 15.51 | 15.83 | 11.09 | 7.4 | 7.12 | 5.58 |
Operating Expenses | 162 | 149.35 | 146.95 | 142.2 | 130.75 | 151.28 |
Operating Income | 33.66 | 51.42 | 91.24 | 58.36 | 3.65 | 58.24 |
Interest Expense | -8.43 | -6.83 | -3.72 | -4.37 | -4.46 | -2.96 |
Interest & Investment Income | 4.69 | 5.95 | 5.42 | 3.33 | 1.03 | 1.6 |
Currency Exchange Gain (Loss) | 13.12 | 13.12 | 13.42 | 7.34 | 13.18 | 3.93 |
Other Non Operating Income (Expenses) | 11.24 | 7.82 | 4.9 | 3.02 | 3.33 | 1.52 |
EBT Excluding Unusual Items | 54.27 | 71.47 | 111.26 | 67.67 | 16.73 | 62.33 |
Gain (Loss) on Sale of Assets | -0.02 | -0.02 | 0.4 | 1.19 | 1.18 | 0.19 |
Asset Writedown | - | - | -4.28 | -14.61 | - | - |
Other Unusual Items | 0.08 | 0.08 | - | - | 0.06 | - |
Pretax Income | 54.34 | 71.53 | 107.38 | 54.25 | 17.98 | 62.52 |
Income Tax Expense | 18.78 | 17.29 | 18.26 | 14.16 | 3.71 | 23.75 |
Net Income | 35.56 | 54.25 | 89.12 | 40.09 | 14.27 | 38.77 |
Net Income to Common | 35.56 | 54.25 | 89.12 | 40.09 | 14.27 | 38.77 |
Net Income Growth | -50.94% | -39.13% | 122.31% | 180.93% | -63.20% | -61.49% |
Shares Outstanding (Basic) | 58 | 56 | 51 | 47 | 45 | 42 |
Shares Outstanding (Diluted) | 60 | 59 | 53 | 47 | 45 | 42 |
Shares Change | 8.13% | 12.08% | 11.20% | 3.98% | 8.91% | -2.73% |
EPS (Basic) | 0.61 | 0.97 | 1.76 | 0.85 | 0.31 | 0.93 |
EPS (Diluted) | 0.59 | 0.92 | 1.69 | 0.85 | 0.31 | 0.92 |
EPS Growth | -54.18% | -45.41% | 99.99% | 171.85% | -66.31% | -60.45% |
Free Cash Flow | -195.42 | -88.46 | 46.56 | 85.17 | 52.87 | -98.89 |
Free Cash Flow Per Share | -3.24 | -1.50 | 0.89 | 1.80 | 1.16 | -2.37 |
Dividend Per Share | 0.195 | 0.195 | 1.460 | 0.681 | 0.360 | 0.308 |
Dividend Growth | -77.01% | -86.67% | 114.29% | 89.20% | 17.10% | -78.25% |
Gross Margin | 22.08% | 25.77% | 32.01% | 27.32% | 19.85% | 28.92% |
Operating Margin | 3.80% | 6.60% | 12.26% | 7.95% | 0.54% | 8.04% |
Profit Margin | 4.01% | 6.96% | 11.98% | 5.46% | 2.11% | 5.35% |
Free Cash Flow Margin | -22.05% | -11.36% | 6.26% | 11.60% | 7.81% | -13.65% |
EBITDA | 113.5 | 113.78 | 141.78 | 108 | 51.54 | 100.5 |
EBITDA Margin | 12.81% | 14.61% | 19.05% | 14.71% | 7.61% | 13.87% |
D&A For EBITDA | 79.84 | 62.36 | 50.54 | 49.64 | 47.89 | 42.25 |
EBIT | 33.66 | 51.42 | 91.24 | 58.36 | 3.65 | 58.24 |
EBIT Margin | 3.80% | 6.60% | 12.26% | 7.95% | 0.54% | 8.04% |
Effective Tax Rate | 34.56% | 24.16% | 17.00% | 26.11% | 20.62% | 37.98% |